Lung Cancer
A Phase 1/2 Dose Escalation/Expansion Study of NGM707 as Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies (NGM707-IO-101)
- Details
ClinicalTrials.gov ID:
NCT04913337
Diagnosis Type:
NA
USOR Number:
- Address
5050 NE Hoyt St, Suite 256
Portland, OR 97213
P: (503) 239-7767